Amplia Therapeutics Limited advised that CEO Dr. John Lambert, has given notice of his resignation to the Board. It is expected that Dr. Lambert will leave the Company in November 2022 but will be available to assist with an orderly transition of the role.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.071 AUD | -1.39% | +1.43% | -11.25% |
05-30 | Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
05-15 | Amplia Therapeutics Completes AU$4.27 Million Entitlement Offer; Shares Up 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-11.25% | 12.92M | |
+18.29% | 125B | |
+15.43% | 108B | |
-6.68% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-13.86% | 16.34B | |
+0.41% | 13.56B | |
+24.61% | 11.59B |
- Stock Market
- Equities
- ATX Stock
- News Amplia Therapeutics Limited
- Amplia Therapeutics Limited Announces CEO Changes